Coronado Biosciences

Biotechnology ResearchNew York, United States11-50 Employees

Coronado Biosciences is a biotechnology research company based in New York, New York, focused on developing novel immunotherapy approaches for cancer and inflammatory diseases. Its lead program involves activating natural killer cells to target and destroy cancer cells, with initial clinical development planned for inflammatory bowel disease, multiple sclerosis, and acute myeloid leukemia. The company positions itself within the biopharmaceutical sector by pursuing therapies that leverage the patient’s immune system to recognize and kill malignant cells, informed by preclinical data indicating activity against several hematologic and solid tumors. Coronado operates with a relatively small team and centers its research efforts in immunotherapy, aiming to address unmet needs in oncology and inflammatory conditions. A recent development noted is the acquisition of exclusive worldwide rights to CNDO-109 from an affiliate of University College London to advance this NK cell–mediated approach for cancer treatment.

Sign up for free to view info

Email Format Employee directory